April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had statistically significant reductions in average blood pressure over 24 hours...
Hypertension
This page includes news and new technology on hypertension. The condition is caused by abnormally high blood pressure that causes excess force and pressure of the blood against the artery walls. Long-term, this can cause damage the vessels and contributes to heart disease. Therapies include antihypertensive medications such as diurestics and renal denervation therapy.
-
-
March 16, 2020 — The European Society of Cardiology (ESC) issued a...
-
The U.S. Food and Drug Administration (FDA) approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other...
-
Investigators unveiled late-breaking clinical data from a first-of-its-kind physician sponsored clinical trial at the 2019 EuroPCR Annual Meeting, May 20-23 in Paris, France. The data indicate...
SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to treat a variety of hypertensive disorders, announced that it has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).
News | Renal Denervation | December 09, 2020
December 9, 2020 — SoniVie, an Israeli company developing the Therapeutic Intra-Vascular Ultrasound (TIVUS) System to...
News | Hypertension | July 15, 2020
July 15, 2020 – Omron Healthcare Inc. and Mount Sinai Health System, New York City’s largest academic medical system,...
The Medtronic Symplicity Spyral renal denervation catheter in the renal artery, showing how its four electrodes contact the vessel wall for a single RF energy delivery procedure. By ablating the vessel walls, it props the vessel in a fully open position, allowing the kidneys to better filter the blood and remove excess water in hypertension patients.
News | Renal Denervation | June 26, 2020
June 26, 2020 – New data from the Global SYMPLICITY Registry (GSR) showed that renal denervation (RDN) with the...
News | Hypertension | April 30, 2020
April 30, 2020 — A large study in adolescents and children, some as young as 3 years of age, shows a link between...
News | Coronavirus (COVID-19) | April 08, 2020
April 8, 2020 — There has been debate in the past month or so during the novel coronavirus (COVID-19) pandemic whether...
News | Renal Denervation | April 01, 2020
April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had...
News | Renal Denervation | April 01, 2020
April 1, 2020 — Three months after undergoing renal denervation (RDN), patients with untreated high blood pressure had...
News | Coronavirus (COVID-19) | March 16, 2020 | Dave Fornell, Editor
March 16, 2020 — The European Society of Cardiology (ESC) issued a statement March 13 recommending in novel coronavirus...
The Aria CV Pulmonary Hypertension System.
News | Hypertension | February 27, 2020
February 27, 2020 — Aria CV Inc. completed a $31 million Series B round of financing to fund its first clinical study...
News | Hypertension | February 07, 2020
February 7, 2020 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the Aria...
The BackBeat CNT system is a bioelectronic treatment that immediately, substantially and chronically lowers blood pressure (BP) while simultaneously modulating the autonomic nervous system (ANS).
News | Hypertension | October 10, 2019
October 10. 2019 — Late-breaking results from its MODERATO II double-blind, randomized study of BackBeat Cardiac...
Image courtesy of the American Heart Association
News | Hypertension | August 20, 2019
August 20, 2019 — In a study that spanned two and a half decades and looked at data from more than 4,700 participants,...
Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels and inhibit the production of stress-related hormones to reduce heart failure symptoms.
Technology | Heart Failure | August 19, 2019
August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo System for the...
News | Hypertension | August 14, 2019
August 14, 2019 — People enrolled in a large clinical hypertension management trial were half as likely to control...
Screen grab of facial scan from the app. Image courtesy of Kang Lee.
News | Blood Pressure Monitor | August 06, 2019
August 6, 2019 — Blood pressure monitoring might one day become as easy as taking a video selfie, according to new...
